BMAL1 and Parkinson disease: In contrast, astrocyte- or microglia-specific BMAL1 deletion does not induce dopaminergic neuron loss, though BMAL1’s role in these glial cells influences redox balance and gliosis, which are relevant to Alzheimer’s and Parkinson’s pathology.